One 100-mg IDHIFA tablet once daily.
Swallow whole with water. Do not split or crush the tablets.
Take IDHIFA tablets orally about the same time each day with or without food.
For patients without disease progression or unacceptable toxicity, treat for a minimum of 6 months to allow time for clinical response
|Adverse reaction||Recommended action|
|Noninfectious leukocytosis (WBC count greater than 30x109/L)|
|Elevation of bilirubin greater than 3x the ULN sustained for ≥2 weeks without elevated transaminases or other hepatic disorders|
ULN, upper limit of normal.
RECOMMENDATIONS FOR OTHER GRADE 3a OR HIGHER TOXICITY CONSIDERED RELATED TO TREATMENT, INCLUDING TLS
aGrade 1 is mild, Grade 2 is moderate, Grade 3 is serious, Grade 4 is life-threatening.
Patients must meet the following criteria to enroll:
Additional Terms and Conditions of the Celgene Commercial Co-pay Programs
© 2017 Celgene Corporation 06/17 US-CELG170216